Comparing the non-operated patients with hypothalamic obesity with patients having obesity (who underwent MBS or not) and lean controls, a significant increase was observed in the post-prandial GLP-1 levels in patients with hypothalamic obesity who underwent MBS [31]. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.